Latest News

Update – Ocrelizumab for Primary Progressive MS in Canterbury

May 29, 2024 | Life with MS, News, Progressive, Treatments

On Wednesday 15 May, Multiple Sclerosis NZ raised how critical workforce shortages are impacting patients with Primary Progressive MS (PPMS) access to time sensitive disease modifying therapies. A business case prepared by clinical specialists had been under review for five […]